About Dr. Banker

Dr Rajesh BankerDr. Rajesh Banker is a double board-certified cardiac electrophysiologist in Southern California. In private practice since 2010, Dr. Banker specializes in the treatment of common and complex heart arrythmias, most often Atrial Fibrillation or Afib. Dr. Banker offers a wide range of solutions both noninvasive and minimally invasive for the prevention of stroke due to arrhythmia. He also specializes in the latest minimally invasive curative treatments for Afib including RF catheter ablation and cryo-ablation using advanced non-radiation guidance techniques.

He trains physicians around the country in both  ablations and new techniques and commonly hosts physicians to guide them in the latest technology.

Licensure/Board Certification

  • Board Certified, Cardiovascular Disease
  • Board Certified, Cardiac Electrophysiology
  • Licensed Physician and Surgeon, California

Medical Education

Fellowship: UCLA/Kaiser Los Angeles Medical Center, Los Angeles, California
Clinical Cardiac Electrophysiology Fellow, July 2009 – June 2010

California Pacific Medical Center San Francisco, California
Co-Chief Cardiology Fellow, July 2008 – June 2009
Clinical Cardiology Fellow, July 2006 – June 2008

Residency: Cedars-Sinai Medical Center Los Angeles, California
Internal Medicine Resident, June 2003 – June 2006

Medical School: Northwestern University School of Medicine, Chicago, Illinois
Doctor of Medicine, May 2003

Graduate Education

Masters in Public Health, Epidemiology/Biostatistics and Tropical Medicine, December 2003
Northwestern University School of Public Health Chicago, Illinois

Health Services Management, 1998-2000
Kellogg Graduate School of Management, Chicago, Illinois

Undergraduate Education

Bachelors of Arts, Physiology
Northwestern University Evanston, Illinois

Peer Reviewed Publications/Book Chapters

  • Hindricks, G, Banker R et al. Performance and Safety Evaluation of a Modified Aveir Leadless Pacemaker in the Right Atrium <ahead of publication> 2021
  • Hsu, J Banker R et al. Characteristics of Atrial Lesion Safety and Efficacy Utilizing an Irreversible Electroporation Circular Catheter and Generator with an In Vivo Porcine Model accepted abstractEHRA 2021
  • Tjong, F Banker R et al The learning curve associated with the implantation of the Nanostim leadless pacemaker J Interv Card Electrophysiol 2018 Nov
  • Cantillon D,Banker R et al Comparative study of acute and mid-term complicationas with leadless and transvenous cardiac pacemakers Heart Rhythm 2018 Jul
  • Kiwata H Banker R et al Nanostim leadless pacemaker system: A longer waiting period after active fixation may reduce unnecessary repositioning 2017 Dec
  • Ip, J, Banker R et al Leadless Cardiac Pacemaker: Does anatomical Position Affect Long Term Electrical Performance?  J Biomed Sci and Eng 2017 Jun
  • Reddy V Banker R et al. Health-Related Quality of Life in Patients with Leadless Pacemaker EP Europace 2016 Jun
  • Reddy V, Banker R., et al.. Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker.New England Journal of Medicine, 2015 Sep 17;373(12):1125-35
  • Aryana A, Banker R, et al. Acute and Long-Term Outcomes of Catheter Ablation of Atrial Fibrillation Using the Second-Generation Cryoballoon versus Open-Irrigated Radiofrequency: A Multicenter Experience.  J Cardiovasc Electrophysiol 2015 Aug 4;26(8):832-9.
  • Patel, A., Banker, R., “Clinical experience with a novel fetal heart monitor approach to preventing phrenic nerve injury during cyroballoon ablation of atrial fibrillation.”  EHRA EUROPACE – CARDIOSTIM 2015. Milan, Italy. May 2015
  • Banker, R, Goldschlager N.: Improper device implantation. In Natale, A., Wang, P,  DiMarco J, and Al-Ahmad, A. (eds) Cardiac Electrophysiology: Clinical Case Review, 2010
  • Banker, R., Mitchell, C., Badhwar, N., Goldschlager, N.: Pacemaker and Implantable Cardioverter Defibrillator Emergencies. In Jeremias, A., Brown, D (eds): Cardiac Intensive Care, 2nd edition, Elsevier; 2009 Ch 31
  • Banker R., Goldschlager, N. Electrocardiogram artifacts: How to recognize them to avoid erroneous diagnosis and possible mismanagement. Journal of Electrocardiology 2009
  • Ren, X., Banker, R. Cardiac manifestation of mucocutaneous lymph node syndrome (Kawasaki’s Disease) J Am Coll Cardiol 2009 Jun 30;54(1):89
  • Banker R., Mitchell, C., Goldschlager, N. Electrocardiogram artifacts: How to recognize them to avoid erroneous diagnosis and possible mismanagement. Journal of Electrocardiology 41 (2008) 38
  • Jeffrey A. Kline, MD; Elizabeth G. Israel, MD, Banker R.; et al. Diagnostic Accuracy of a Bedside D-dimer Assay and Alveolar Dead-Space Measurement for Rapid Exclusion of Pulmonary Embolism: A Multicenter Study. JAMA 2001; 285: 761-768
  • Fatal Fulminant Myocarditis Without An Identified Causative Organism – Solomon Scholars     Research Foundation, 2004 <poster>

Research

  • Principal Investigator, HELIOS IDE trial: IDE trial for novel RF ablation system Biosense Webster/J&J
  • Principal Investigator, STOP-AF First trial: Evaluation AF ablation as a first line therapy, Medtronic
  • Principal Investigator, BEAT-HF IDE trial: Novel Barostimulation IDE product for the treatment of congestive heart failure Biosense Webster/J&J
  • Principal Investigator, LEADLESS II IDE Cardiac Pacemaker trial: IDE trial for entirely intracardiac pacemaker, ongoing <St Jude Medical> | Reddy V, Banker R., et al.. Percutaneous Implantation of an Entirely Intracardiac Leadless Pacemaker. New England Journal of Medicine, N Engl J Med. 2015 Sep 17;373(12):1125-35
  • Principal Investigator, REAFFIRM trial: Investigating the efficacy of the TOPERA atrial fibrillation ablation system | Abbott
  • Principal Investigator, nMARQ IDE trial: Novel IDE product for the ablation of paroxysmal atrial fibrillation | Biosense Webster/J&J
  • Principal Investigator, Multipoint Pacing Protocol (MPP) IDE trial: Novel IDE Biventricular ICD with multipoint LV pacing for cardiac resynchronization therapy | Jude Medical, closed to new enrollment with patients in ongoing follow-up
  • Principal Investigator, VICTORY-AF IDE trial: Novel IDE product for the ablation of chronic atrial fibrillation | Medtronic
  • Principal Investigator, QUARTET IDE trial: Novel IDE product for cardiac resynchronization therapy | St Jude Medical, ongoing
  • Principal Investigator, QUAD-PAS trial: Post approval study of the quadripolar biventricular pacing lead | St Jude Medical, closed to new enrollment with patients in ongoing follow-up

Honors & Awards

  • Physician of Excellence, Orange County 2019
  • Cedars-Sinai Medical Center: Solomon Scholars Research Award – awarded for “outstanding original research performed during residency”